"Translational Research and Medicine Development" course by Bayer in Berlin on 16.-20. April 2018
Interested in discovering the landscape of Translational Medicine? Want to learn about the job profiles of scientists in Industry? Then join the 2018 course "Translational Research and Medicine Development" which will be hosted by Bayer in Berlin from 16.-20. April 2018 as part of the Marie Curie project ENLIGHT-TEN. The fee of 300 Euro includes the 5 day course in Berlin, catering during the course, two dinners and the e-learning. For more information seehttp://www.helmholtz-hzi.de/enlightten_course or attached draft programme and fact sheet. Review of application documents will be on a first come, first serve basis.
The ENLIGHT-TEN summer school 2018 builds on the experience of the C-COMEND project, which in 2016 & 2017 delivered two highly valued courses. This what the students say:
- If you have the opportunity to take part in this course – do it. It will fundamentally change your view on how your work as a research scientist can make a difference in the real world outside your lab (Konstantin Kuhne)
- Very interactive course with a non-traditional approach. The course reflects the reality of translational medicine: getting a lot of people with different backgrounds to work together as a team (Miriam Ayuso)
- My expectations to the course were very high, and they were fulfilled (Sandra Heckers)
- It was a difficult decision to leave the lab for 5 days but it absolutely worth it (Kevin Ferreira)
Confirmed speakers
Bob Harris, Professor Immunotherapy, Karolinska
Matthias Gottwald, Head of R&D Policy & Networking, Bayer AG
Keith Williams, Director, KW Drug Developments
Jörg Lippert Global Head Clinical Pharmacometrics, VP at Bayer AG
Find out more
rebecca.ludwig@helmholtz-hzi.de
Registration site: http://www.helmholtz-hzi.de/enlightten_course